Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
32.59
-2.41 (-6.89%)
At close: May 22, 2026, 4:00 PM EDT
33.13
+0.54 (1.66%)
After-hours: May 22, 2026, 7:49 PM EDT
Eton Pharmaceuticals Employees
Eton Pharmaceuticals had 44 employees as of December 31, 2025. The number of employees increased by 13 or 41.94% compared to the previous year.
Employees
44
Change (1Y)
13
Growth (1Y)
41.94%
Revenue / Employee
$1,975,773
Profits / Employee
-$33,523
Market Cap
892.72M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 44 | 13 | 41.94% |
| Dec 31, 2024 | 31 | 1 | 3.33% |
| Dec 31, 2023 | 30 | 2 | 7.14% |
| Dec 31, 2022 | 28 | 11 | 64.71% |
| Dec 31, 2021 | 17 | 1 | 6.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evotec SE | 4,526 |
| Amphastar Pharmaceuticals | 1,976 |
| Alvotech | 1,279 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
| Xeris Biopharma Holdings | 435 |
| Collegium Pharmaceutical | 423 |
| Harrow | 373 |
ETON News
- 5 days ago - Eton Pharmaceuticals enters supply, distribution agreement for Impavido - TheFly
- 5 days ago - Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine) - GlobeNewsWire
- 9 days ago - Eton Pharmaceuticals price target raised to $57 from $52 at H.C. Wainwright - TheFly
- 9 days ago - Eton Pharmaceuticals Q1 Earnings Call Highlights - MarketBeat
- 10 days ago - Eton Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 10 days ago - Eton Pharmaceuticals Earnings release: Q1 2026 - Filings
- 10 days ago - Eton Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 10 days ago - Eton Pharmaceuticals Reports First Quarter 2026 Financial Results - GlobeNewsWire